Anurag Mehta Selected Research

Tyrosine Kinase Inhibitors

6/2022	IHC versus FISH versus NGS to detect ALK gene rearrangement in NSCLC: all questions answered?
1/2021	Rare epidermal growth factor receptor gene alterations in non-small cell lung cancer patients, tyrosine kinase inhibitor response and outcome analysis.
1/2020	Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of "Lung Cancer Management in Indian context".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anurag Mehta Research Topics

Disease

36	Neoplasms (Cancer) 03/2024 - 04/2006
25	Cardiovascular Diseases (Cardiovascular Disease) 06/2024 - 01/2020
11	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2015
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 07/2014
9	Carcinoma (Carcinomatosis) 05/2024 - 01/2014
9	Adenocarcinoma of Lung 10/2023 - 01/2013
6	Neoplasm Metastasis (Metastasis) 02/2024 - 12/2015
6	COVID-19 01/2022 - 04/2020
5	Atherosclerosis 02/2024 - 01/2018
5	Adenocarcinoma 01/2024 - 10/2015
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2019
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
4	Obesity 02/2024 - 01/2023
4	Inflammation (Inflammations) 12/2023 - 01/2018
4	Coronary Disease (Coronary Heart Disease) 03/2023 - 01/2019
4	Hypertension (High Blood Pressure) 01/2023 - 01/2021
3	Weight Loss (Weight Reduction) 02/2024 - 01/2023
3	Infections 07/2023 - 04/2006
3	Diabetes Mellitus 01/2023 - 01/2019
3	Triple Negative Breast Neoplasms 01/2020 - 01/2014
2	Dyslipidemias (Dyslipidemia) 03/2024 - 11/2023
2	Overweight 02/2024 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 02/2024 - 10/2023
2	Heart Failure 01/2024 - 01/2023
2	Non-alcoholic Fatty Liver Disease 11/2023 - 11/2023
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2022 - 01/2021
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2022 - 06/2021
2	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 12/2018
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 11/2015
2	Myocardial Infarction 11/2021 - 11/2020
2	Prostatic Neoplasms (Prostate Cancer) 08/2021 - 07/2015
2	Stroke (Strokes) 11/2020 - 01/2020
2	Anemia 10/2019 - 07/2019
2	Ovarian Neoplasms (Ovarian Cancer) 03/2019 - 01/2018
2	Lactic Acidosis 01/2019 - 11/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2018 - 01/2018
2	Lymphoma (Lymphomas) 01/2018 - 07/2017
2	Multiple Myeloma 10/2015 - 09/2011
1	Aortic Valve Stenosis (Aortic Stenosis) 05/2024
1	Insulin Resistance 03/2024
1	Fibrosis (Cirrhosis) 03/2024

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 11/2023 - 07/2014
9	Lipoprotein(a)IBA 06/2024 - 01/2020
9	ErbB Receptors (EGF Receptor)IBA 05/2024 - 01/2013
9	CalciumIBA 02/2024 - 01/2018
7	LipidsIBA 03/2024 - 01/2019
6	oxidized low density lipoproteinIBA 06/2024 - 01/2020
5	LDL CholesterolIBA 06/2024 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2018
4	Anaplastic Lymphoma KinaseIBA 06/2022 - 04/2013
4	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 09/2016
3	RNA (Ribonucleic Acid)IBA 02/2024 - 07/2017
3	Formaldehyde (Formol)FDA Link 01/2024 - 01/2014
3	ParaffinIBA 01/2024 - 01/2014
3	HDL CholesterolIBA 11/2023 - 01/2020
3	Phosphotransferases (Kinase)IBA 10/2023 - 01/2018
3	AntigensIBA 07/2023 - 06/2021
3	Tyrosine Kinase InhibitorsIBA 06/2022 - 01/2020
3	Keratins (Keratin)IBA 04/2022 - 03/2017
3	human ERBB2 proteinIBA 01/2022 - 11/2020
3	Cell-Free Nucleic AcidsIBA 12/2021 - 10/2020
3	Hormones (Hormone)IBA 10/2021 - 01/2015
3	CrizotinibIBA 01/2020 - 09/2017
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2015 - 01/2009
2	Lipoproteins (Lipoprotein)IBA 06/2024 - 11/2023
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 02/2024 - 01/2023
2	tirzepatideIBA 02/2024 - 01/2023
2	CateninsIBA 01/2024 - 10/2015
2	Urokinase Plasminogen Activator ReceptorsIBA 12/2023 - 01/2020
2	C-Reactive ProteinIBA 12/2023 - 11/2021
2	ApolipoproteinsIBA 11/2023 - 01/2022
2	CholesterolIBA 07/2023 - 01/2019
2	Nucleic AcidsIBA 07/2023 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 01/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2022
2	Salivary Proteins and PeptidesIBA 01/2022 - 03/2019
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	Phenobarbital (Luminal)FDA Link 10/2021 - 04/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 01/2013
2	Androgen Receptors (Androgen Receptor)IBA 07/2019 - 07/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 11/2018
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2018
2	Liraglutide FDA Link 01/2019 - 11/2018
2	Hematoxylin (Haematoxylon)IBA 09/2018 - 03/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 09/2018 - 03/2017
2	Trastuzumab (Herceptin)FDA Link 09/2018 - 04/2017
2	Epidermal Growth Factor (EGF)IBA 01/2015 - 01/2014
2	Estrogen ReceptorsIBA 01/2015 - 01/2014
1	Mutant Proteins (Protein, Mutant)IBA 05/2024
1	SMARCB1 ProteinIBA 03/2024
1	Sucrose (Saccharose)IBA 03/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2024

Therapy/Procedure

26	Therapeutics 05/2024 - 01/2009
6	Drug Therapy (Chemotherapy) 06/2021 - 12/2014
4	Radiotherapy 01/2021 - 09/2011
3	Hysterectomy 01/2024 - 07/2011
2	Obesity Management 01/2024 - 09/2023
2	Immunotherapy 01/2021 - 01/2021
1	Secondary Prevention 06/2024